MoneyWorks4Me

Neuland Laboratories informs about analyst meet

12 Sep 2018 Evaluate

Pursuant to Regulation 30(6) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, Neuland Laboratories has informed about the details of the Analyst/Institutional Investor meeting on September 11, 2018, at Hyderabad.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..